BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35137142)

  • 21. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
    Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
    Belokovskaya R; Ravikumar A; Arumugam D; Izadmehr S; Goddard GM; Geer EB; Levine AC
    Endocr Pract; 2019 Aug; 25(8):846-853. PubMed ID: 31070948
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
    Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
    Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
    Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG; Bayraktar F; Yilmaz C
    Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion.
    Šojat AS; Dunjić-Kostić B; Marina LV; Ivović M; Radonjić NV; Kendereški A; Ćirković A; Tančić-Gajić M; Arizanović Z; Mihajlović S; Vujović S
    J Endocrinol Invest; 2021 Sep; 44(9):1935-1945. PubMed ID: 33528757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion.
    Carafone LE; Zhang CD; Li D; Lazik N; Hamidi O; Hurtado MD; Young WF; Thomas MA; Dy BM; Lyden ML; Foster TR; McKenzie TJ; Bancos I
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34203283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
    Puglisi S; Leporati M; Amante E; Parisi A; Pia AR; Berchialla P; Terzolo M; Vincenti M; Reimondo G
    Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
    J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.
    Di Dalmazi G; Vicennati V; Pizzi C; Mosconi C; Tucci L; Balacchi C; Cosentino ER; Paolisso P; Fanelli F; Gambineri A; Pelusi C; Repaci A; Garelli S; Galiè N; Borghi C; Golfieri R; Pagotto U
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
    Deutschbein T; Unger N; Hinrichs J; Walz MK; Mann K; Petersenn S
    Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism.
    Nakao H; Yokomoto-Umakoshi M; Nakatani K; Umakoshi H; Ogata M; Fukumoto T; Kaneko H; Iwahashi N; Fujita M; Ogasawara T; Matsuda Y; Sakamoto R; Izumi Y; Bamba T; Ogawa Y
    EBioMedicine; 2023 Sep; 95():104733. PubMed ID: 37543511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
    Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.